volixibat
volixibat: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Phase 3 |
FDA Decisions
FDA_MeetingThe Company has a pre-NDA meeting for volixibat in PSC scheduled with the FDA in summer 2026.(MIRM)
Frequently asked questions
Who is developing volixibat?
volixibat is being developed by Mirum Pharmaceuticals, Inc..
What is volixibat's latest FDA decision?
The most recent tracked FDA decision for volixibat is FDA_Meeting for The Company has a pre-NDA meeting for volixibat in PSC scheduled with the FDA in summer 2026..
Get deeper analysis on volixibat
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis